[1] 周 勇,侯晓群,王伟民.垂体腺瘤的发病机理[J].世界最新医学信息文摘, 2019(26):3.
[2] Melmed S.Pituitary-tumor endocrinopathies[J].N Engl J Med,2020,382:937-950.
[3] 陈灏珠.实用内科学.第12版.北京:人民卫生出版社,2005.
[4] Lopes M B S.The 2017 World Health Organization classification of tumors of the pituitary gland: a summary[J].Acta Neuropathol,2017.134:521-535.
[5] Villa C, Vasiljevic A, Jaffrain-Rea M L, et al .A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group(EPPG)proposal[J]. Virchows Arch, 2019,475:687-692.
[6] 中国垂体腺瘤协作组,中华医学会神经外科学分会,中国难治性垂体腺瘤诊治专家共识(2019)[J].中华医学杂志,2019,99:1454-1459
[7] Puglisi S, Terzolo M.Hypertension and acromegaly[J].Endocrinol Metab Clin North Am, 2019,48:779-793.
[8] Malchiodi E, Profka E, Ferrante E, et al.Thyrotropin-secreting pituitary adenomas:outcome of pituitary surgery and irradiation[J]. J Cling Endocrinol Metab,2014,99(6):2069-2076.